BRUCE ROE: Open Payments
NPI 1356433262 · ROCKLIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,855 in 83 payments from 21 companies in 2025. Trend: 2023 $2,174 · 2024 $1,780 · 2025 $1,855
Food & beverage: $1,855
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $279 |
| GlaxoSmithKline, LLC. | 13 | $258 |
| Novo Nordisk Inc | 10 | $209 |
| PFIZER INC. | 9 | $165 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $152 |
| Amgen Inc. | 5 | $99 |
| Boston Scientific Corporation | 4 | $89 |
| Phathom Pharmaceuticals, Inc. | 5 | $83 |
| ABBVIE INC. | 4 | $81 |
| Exact Sciences Corporation | 3 | $79 |
Products named: AIRSUPRA, JARDIANCE, AREXVY, TRELEGY ELLIPTA, NURTEC ODT, EVENITY, General - Pain Management, Wegovy.
Industry payments across CA — which companies pay providers there.
